Loading...
Docoh

Kamada (KMDA)

347 filings

Page 9 of 18
Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
6-K
KMDA Kamada Ltd
29 Aug 17
Kamada Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
8:00pm
6-K
KMDA Kamada Ltd
27 Aug 17
Current report (foreign)
8:00pm
6-K
KMDA Kamada Ltd
24 Aug 17
Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB™ for Post-Exposure Prophylaxis Against Rabies Infection
8:00pm
SC 13G/A
KMDA Kamada Ltd
22 Aug 17
Kamada LTD
8:00pm
6-K
KMDA Kamada Ltd
1 Aug 17
Current report (foreign)
8:00pm
424B5
KMDA Kamada Ltd
31 Jul 17
Prospectus supplement for primary offering
8:00pm
6-K
KMDA Kamada Ltd
31 Jul 17
Kamada Reports Financial Results for Second Quarter and First Six Months of 2017
8:00pm
6-K
KMDA Kamada Ltd
27 Jul 17
Kamada Announces Pricing of Public Offering of
8:00pm
424B5
KMDA Kamada Ltd
26 Jul 17
Prospectus supplement for primary offering
8:00pm
6-K
KMDA Kamada Ltd
26 Jul 17
Kamada Pre-Announces Certain Preliminary Financial Results for Second Quarter and First
8:00pm
6-K
KMDA Kamada Ltd
19 Jul 17
Current report (foreign)
8:00pm
CORRESP
KMDA Kamada Ltd
12 Jul 17
Correspondence with SEC
8:00pm
EFFECT
KMDA Kamada Ltd
12 Jul 17
Notice of effectiveness
8:00pm
CORRESP
KMDA Kamada Ltd
11 Jul 17
Correspondence with SEC
8:00pm
6-K
KMDA Kamada Ltd
21 Jun 17
Kamada Announces Withdrawal of European Marketing Authorization Application for Inhaled Alpha-1-Antitrypsin
8:00pm
6-K
KMDA Kamada Ltd
11 Jun 17
Current report (foreign)
8:00pm
6-K
KMDA Kamada Ltd
6 Jun 17
Kamada Provides Update on Clinical Program for Alpha-1 Antitrypsin IV for Treatment of Graft-Versus-Host Disease
8:00pm
6-K
KMDA Kamada Ltd
4 Jun 17
Kamada Announces Appointment of Michal Stein, M.D., as Vice President and Medical Director
8:00pm
6-K
KMDA Kamada Ltd
23 May 17
Kamada Presents Updated Data from Phase 2 Clinical Trial of Inhaled Alpha-1-Antitrypsin
8:00pm
6-K
KMDA Kamada Ltd
15 May 17
Kamada Reports 2017 First Quarter Financial Results
8:00pm